Literature DB >> 16193897

Validation of the NARCOMS registry: fatigue assessment.

Ruth Ann Marrie1, Gary Cutter, Tuula Tyry, Olympia Hadjimichael, Denise Campagnolo, Timothy Vollmer.   

Abstract

Participants in the North American Research Committee on Multiple Sclerosis (NARCOMS) Registry report disability using Performance Scales (PS), which assess eight domains. We aimed to validate the PS fatigue subscale (PSF) using the Fatigue Severity Scale (FSS) and the Modified Fatigue Impact Scale (MFIS) as external criteria. We measured correlations between the PSF and age, disease duration and PS subscales to assess construct validity. The PSF correlated strongly with the MFIS (r =0.72, P <0.0001) and FSS (r =0.75, P <0.0001). Correlations between the PSF and age, disease duration were low, indicating divergent validity. Correlations between the PSF and spasticity, sensory and mobility PS scales were moderate, indicating convergent validity. The PSF has adequate criterion and construct validity in MS.

Entities:  

Mesh:

Year:  2005        PMID: 16193897     DOI: 10.1191/1352458505ms1216oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  17 in total

1.  Post-stroke fatigue level is significantly associated with mental health component of health-related quality of life: a cross-sectional study.

Authors:  Khader A Almhdawi; Hanan B Jaber; Hanan W Khalil; Saddam F Kanaan; Awni A Shyyab; Zaid M Mansour; Alza H Alazrai
Journal:  Qual Life Res       Date:  2021-01-02       Impact factor: 4.147

2.  Smokers with MS have greater decrements in quality of life and disability than non-smokers.

Authors:  Farren Bs Briggs; Douglas D Gunzler; Daniel Ontaneda; Ruth Ann Marrie
Journal:  Mult Scler       Date:  2017-01-06       Impact factor: 6.312

3.  Physical and Mental Health-Related Quality of Life Trajectories Among People With Multiple Sclerosis.

Authors:  Julia O'Mahony; Amber Salter; Beyza Ciftci; Robert J Fox; Gary R Cutter; Ruth Ann Marrie
Journal:  Neurology       Date:  2022-08-10       Impact factor: 11.800

Review 4.  Central fatigue in multiple sclerosis: a review of the literature.

Authors:  Pamela Newland; Angela Starkweather; Matthew Sorenson
Journal:  J Spinal Cord Med       Date:  2016-05-05       Impact factor: 1.985

5.  The multiple sclerosis rating scale, revised (MSRS-R): development, refinement, and psychometric validation using an online community.

Authors:  Paul Wicks; Timothy E Vaughan; Michael P Massagli
Journal:  Health Qual Life Outcomes       Date:  2012-06-18       Impact factor: 3.186

6.  Use of an online community to develop patient-reported outcome instruments: the Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ).

Authors:  Paul Wicks; Michael Massagli; Amit Kulkarni; Homa Dastani
Journal:  J Med Internet Res       Date:  2011-01-24       Impact factor: 5.428

Review 7.  Self-report fatigue questionnaires in multiple sclerosis, Parkinson's disease and stroke: a systematic review of measurement properties.

Authors:  Roy G Elbers; Marc B Rietberg; Erwin E H van Wegen; John Verhoef; Sharon F Kramer; Caroline B Terwee; Gert Kwakkel
Journal:  Qual Life Res       Date:  2011-10-20       Impact factor: 4.147

8.  Lifestyle factors, demographics and medications associated with depression risk in an international sample of people with multiple sclerosis.

Authors:  Keryn L Taylor; Emily J Hadgkiss; George A Jelinek; Tracey J Weiland; Naresh G Pereira; Claudia H Marck; Dania M van der Meer
Journal:  BMC Psychiatry       Date:  2014-12-03       Impact factor: 3.630

9.  Methodology of an International Study of People with Multiple Sclerosis Recruited through Web 2.0 Platforms: Demographics, Lifestyle, and Disease Characteristics.

Authors:  Emily J Hadgkiss; George A Jelinek; Tracey J Weiland; Naresh G Pereira; Claudia H Marck; Dania M van der Meer
Journal:  Neurol Res Int       Date:  2013-04-11

10.  Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey.

Authors:  Olympia Hadjimichael; Timothy Vollmer; MerriKay Oleen-Burkey
Journal:  Health Qual Life Outcomes       Date:  2008-11-14       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.